327 related articles for article (PubMed ID: 28501122)
1. Association of patient age with high-risk pathologic features in papillary thyroid cancer.
Niemann AC; Reid AT; Smith J; Hammond J; DeBolle SA; Wei I; Soong-Ho Lee C; Hughes DT
J Surg Res; 2017 May; 211():228-232. PubMed ID: 28501122
[TBL] [Abstract][Full Text] [Related]
2. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
[TBL] [Abstract][Full Text] [Related]
3. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
Kim HJ; Sohn SY; Jang HW; Kim SW; Chung JH
World J Surg; 2013 Feb; 37(2):376-84. PubMed ID: 23135422
[TBL] [Abstract][Full Text] [Related]
4. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
[TBL] [Abstract][Full Text] [Related]
5. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
[TBL] [Abstract][Full Text] [Related]
6. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma.
Jin BJ; Kim MK; Ji YB; Song CM; Park JH; Tae K
Oral Oncol; 2015 Aug; 51(8):759-63. PubMed ID: 26093388
[TBL] [Abstract][Full Text] [Related]
8. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
10. Number of tumor foci predicts prognosis in papillary thyroid cancer.
Qu N; Zhang L; Ji QH; Zhu YX; Wang ZY; Shen Q; Wang Y; Li DS
BMC Cancer; 2014 Dec; 14():914. PubMed ID: 25471041
[TBL] [Abstract][Full Text] [Related]
11. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
12. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of recurrent papillary thyroid cancer.
Zhu J; Wang X; Zhang X; Li P; Hou H
Diagn Pathol; 2015 Jul; 10():96. PubMed ID: 26168921
[TBL] [Abstract][Full Text] [Related]
14. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
15. [Predictors of level V lymphatic metastasis in papillary thyroid carcinoma].
Chen R; Wei T; Li ZH; Gong RX; Zhu JQ
Zhonghua Wai Ke Za Zhi; 2012 Jul; 50(7):625-8. PubMed ID: 22943994
[TBL] [Abstract][Full Text] [Related]
16. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
17. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
18. Vascular invasion is an independent prognostic factor for distant recurrence-free survival in papillary thyroid carcinoma: a matched-case comparative study.
Cao J; Hu JL; Chen C; Wang QL; Fang XH; Zhang Y; Ge MH
J Clin Pathol; 2016 Oct; 69(10):872-7. PubMed ID: 27010434
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma.
Lee HS; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
World J Surg; 2015 Aug; 39(8):1943-50. PubMed ID: 25820911
[TBL] [Abstract][Full Text] [Related]
20. Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors.
Spinelli C; Tognetti F; Strambi S; Morganti R; Massimino M; Collini P
World J Surg; 2018 Aug; 42(8):2444-2453. PubMed ID: 29383423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]